XML 16 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Oct. 31, 2023
Oct. 31, 2022
Income Statement [Abstract]        
Net sales $ 50,436 $ 54,564 $ 100,275 $ 104,687
Cost of products sold 36,968 45,863 74,893 89,790
Gross profit 13,468 8,701 25,382 14,897
Operating expenses 8,359 7,946 16,465 14,538
Operating profit 5,109 755 8,917 359
Pension expense (40) (8) (81) (35)
Other income, net 148 79 223 546
Interest expense (372) (370) (802) (754)
Profit before income taxes 4,845 456 8,257 116
Income tax expense 2,015 570 2,912 949
Net earnings (loss) 2,830 (114) 5,345 (833)
Less: Net earnings attributable to the non-controlling interest 98 129 139 157
Net earnings (loss) attributable to Kewaunee Scientific Corporation $ 2,732 $ (243) $ 5,206 $ (990)
Net earnings (loss) per share attributable to Kewaunee Scientific Corporation stockholders        
Basic (in dollars per share) $ 0.94 $ (0.09) $ 1.81 $ (0.35)
Diluted (in dollars per share) $ 0.93 $ (0.09) $ 1.79 $ (0.35)
Weighted average number of common shares outstanding        
Basic (in shares) 2,903 2,830 2,882 2,819
Diluted (in shares) 2,931 2,830 2,908 2,819